cell and developmental biology
Sep. 18, 2013—Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.
Aug. 30, 2013—Twelve Vanderbilt University faculty members named to endowed chairs were lauded for their extraordinary academic achievements during an Aug. 28 celebration.
Aug. 26, 2013—A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.
Aug. 15, 2013—In an effort to understand how neurons develop different “architectures,” Vanderbilt developmental biologists have discovered a genetic switch that controls one type of neuron branching in the nematode worm.
Jul. 29, 2013—A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.
Jul. 5, 2013—An executive committee has been named and will meet regularly this summer to develop a framework of ideas to guide a university-wide academic strategic planning process that will set the course for Vanderbilt’s future.
Jun. 20, 2013—Diseases associated with mutations and changes in expression of the protein caveolin may result from faulty trafficking of the protein to the cell surface.
Jun. 12, 2013—Antacids that block a certain enzyme pose a risk for a common cardiac problem in premature infants.
May. 10, 2013—A “profile” of the genes and regulatory networks that govern early heart valve development lay the groundwork for generating valves from a patient’s own cells.
Apr. 1, 2013—The gene Has2 participates in signaling that is important in developing fingers and toes, and may have relevance for cancer development.
Feb. 18, 2013—Adult cells in the pancreas can return to a less mature state – and then become a different cell type, like the beta cells that secrete insulin.
Feb. 1, 2013—An unexpected group of cells generates the coronary arteries and may be useful for regeneration therapies following injury to the heart.